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ABSTRACT
Background: All resources are scarce. The ethical dilemma in health care is how to 
balance the precepts of autonomy, beneficence, and distributive justice. Rationing 
may affect three dimensions of coverage: the share of the population covered, the 
services covered, and the extent to which services are covered. 
United States: The US spends 50 percent more per capita on health care than any 
other country while achieving worse health than many. Poorly coordinated insurance 
mechanisms leave 19 percent of the population uninsured. Until passage of the 
Patient Protection and Affordable Care Act (PPACA) in 2010, health care was 
effectively a privilege, not a right. While PPACA seeks to rectify this, by 2019 five 
percent of non-elderly US residents will likely remain uninsured. 
Europe: Most European countries provide universal or near-universal population 
coverage to people resident in the respective country. Central and Eastern European 
countries inherited the Soviet-era commitment to universal coverage free at the 
point of use. Faced with a decline in government spending on health, almost all of 
them reduced the scope of services and introduced official user fees. In contrast, 
other European countries expanded entitlement to publicly funded health care, 
resulting in greater equity. A number of countries have attempted to depoliticize 
decisions on rationing by using health technology assessments and dedicated 
agencies. 
Discussion: Resource allocation and rationing differ considerably between the US 
and Europe. In the US, where social welfare remains controversial, there are few 
restrictions on the use of health care technology regardless of cost or clinical 
effectiveness. European countries engage in more explicit debates about these 
limits, though these are complicated by media and lobby power. 
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Conclusion: The ethical issues in the US largely revolve around rationing care by 
eligibility for insurance coverage, whereas in Europe they are more concerned with 
the scope of publicly funded services to all. On both sides of the Atlantic, public 
debates are needed about the financial sustainability of health systems, the trade-
offs between cost-containment and broader societal and health system goals, the 
role of the welfare state, and the limits of publicly financed health care.
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INTRODUCTION
At some level, all resources are scarce and that is certainly true for health 
care. In the face of scarcity, resources are either explicitly or implicitly 
rationed. Rationing of health care limits access to beneficial health care 
services.1 The central question, then, is not whether health care is rationed, 
but how, by whom and to what degree. The ethical dilemma is how to 
balance the precepts of autonomy, beneficence, and distributive justice.2 
Autonomy would suggest that individuals have a right to determine what is 
in their own best interest, though that interest may be limited if exercising 
that right limits the rights of others. Beneficence means that clinicians 
should act completely in the interest of their patients, and distributive 
justice or equity implies fairness and that all groups have an equal right to 
clinical services regardless of race, gender, age, income, or any other 
characteristic. The utilitarian perspective would suggest that resources for 
medical care should be used to provide the greatest good for the greatest 
number. However, in medical care, the “rule of rescue” is often invoked to 
provide services to the neediest or the most identifiable. A corollary is that 
therapeutic services are often given primacy over preventive services 
regardless of their cost effectiveness. Different countries balance the rights 
of individuals and the fairness in society as a whole in very different ways 
and use very different processes for addressing the legitimacy, transparency, 
and accountability of those explicit or implicit decisions. 
Ultimately, rationing has to be assessed against these broader societal 
and health system goals. Health system goals can be defined in a number of 
ways. One of the most widely quoted attempts, the WHO World Health 
Report 2000, defined the fundamental objectives of health systems as 
improving population health, responding to people’s expectations, and 
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providing financial protection against the costs of ill health.3 Health, of 
course, is not only determined by health care, but also by broader social and 
environmental factors. While equity in health care financing and in access 
to health care services can reduce inequities, equity in health outcomes 
should be another goal of health systems.4,5
TYPES OF RATIONING
All health care systems rely on a mix of public and private systems of 
financing and decisions on rationing are made by actors in both the public 
and private sector, with important differences between the United States 
and Europe. Overall, rationing can affect three dimensions of coverage: 
breadth (the share of the population covered), scope (which services are 
covered) and depth (the extent or cost share to which services are covered).5 
Implicitly or explicitly rationing the breadth of coverage reduces the 
proportion of the population eligible for coverage. This can be through 
means-testing (e.g., excluding those with higher incomes), employment 
(e.g., excluding self-employed people), pricing them out of the market 
(e.g., by making coverage unaffordable for people with pre-existing 
conditions), excluding people from eligibility (e.g., those who do not meet 
certain residency requirements), or by allowing people to opt out. 
Rationing the scope of care by excluding services from the benefits 
package (which may be implicit or explicit and based on a positive or 
negative list) reduces the quantity or quality of clinical care. This can be 
achieved through application of criteria and measures such as effectiveness, 
comparative effectiveness, or cost-effectiveness, and making use of such 
tools as health technology assessments (HTAs), clinical guidelines or 
quality assurance.6 Many health care systems also ration the scope of care 
by waiting lists. 
Rationing the depth of coverage involves user charges. These can be 
based on the value of health care services and imply selective charges 
(co-payments) for inefficient services or reduced charges for especially 
valuable ones (value-based insurance design).7 It can also apply only to 
certain groups of patients, based on eligibility criteria or defined health 
needs. More generalized user charges shift costs to private households and 
may undermine access of lower income groups of the population.8 This 
illustrates that all forms of rationing involve ethical issues and decisions on 
how to balance fiscal constraints with health care system goals such as 
equity, efficiency and improving population health, as well as broader 
societal values.9,10 
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Rationing the different dimensions of coverage takes place at all levels, 
often in an implicit rather than explicit manner.11 In line with the wider 
health system goals of transparency, accountability and patient 
responsiveness, the process of setting priorities and rationing coverage 
(particularly of publicly funded care) should be based on explicit criteria 
and a broad public debate involving government, providers, the public, and 
patients.9,12 However, this does not regularly happen in practice and it is 
often easier for governments (or, in the US, employers) to instead exclude 
whole areas of services, such as dental care.8 Furthermore, much “bedside” 
rationing by clinicians, such as on the basis of age,13 has been traditionally 
implicit and unsystematic.11,12
RESOURCE ALLOCATION AND RATIONING IN THE US
The US spends 50 percent more per capita on health care than any other 
country in the world, some 17.6 percent of GDP in 2009,14 while achieving 
poorer health than many OECD countries.15 At a macro level, medical care 
consumes approximately 97 percent of the health budget—only three 
percent is devoted to public health—with concomitant neglect of many 
social and environmental determinants of health.16 In medical care, poorly 
coordinated insurance mechanisms foster a system that leaves 19 percent of 
the US population uninsured and over USD $750 billion wasted annually in 
unnecessary services (USD $210 billion), administrative waste (USD $190 
billion), inefficiently delivered services (USD $130 billion), high prices 
(USD $105 billion), fraud (USD $75 billion), and missed prevention 
opportunities (USD $55 billion).17,18
Passage of the Patient Protection and Affordable Care Act (PPACA) in 
2010 was meant to change health care from a privilege to a right. Previously, 
insurance coverage was available to those who could afford to purchase 
individual insurance and members of certain groups (largely families of 
workers whose employers paid for coverage), while the elderly (age 65 and 
older) and disabled were covered through the federal Medicare program 
and the poor were entitled to the Medicaid program, but with varying 
entitlements across states. Many fell between the cracks in the system. In 
particular those with pre-existing conditions are still often denied individual 
coverage or charged exorbitant rates, while young adults and undocumented 
or newly arrived residents had little recourse other than to pay cash for care 
or rely on emergency room or charity care. Thus, in part, health care 
resources were allocated based on who was covered by insurance schemes, 
disenfranchising many who could not afford insurance.
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Because of the perceived sanctity of the physician – patient relationship 
and individual decision-making, resources are not limited to services that 
provide value, but, rather, are up to the choices of physicians and patients. 
Physicians and institutions often profit directly from delivery of services 
through fees and ownership of facilities and equipment, resulting in strong 
incentives for overuse. Lack of an integrated system of electronic health 
records leads to needlessly repeated testing, while the lack of critical 
clinical information gives rise to poor decisions and untoward consequences, 
such as unnecessary drug interactions. The threat of malpractice abets 
overuse of clinical care. Incentives are thus poorly aligned with need and 
appropriate use. Heavy promotion of costly drugs and procedures along 
with a lack of price sensitivity on the part of physicians and patients 
further contributes to overuse, though tiered drug co-payments are used to 
encourage use of less costly drugs. 
While PPACA seeks to rectify some of these problems, such as 
beginning to standardize a minimum level of coverage, providing full 
coverage of clinical preventive services, and assuring that health care 
coverage is available to most without regard to pre-existing conditions, 
current estimates are that by 2019, five percent of non-elderly US residents 
will remain uninsured despite the new incentives for coverage and negative 
tax consequences of remaining uninsured. PPACA also established the 
Patient-Centered Outcomes Research Institute (PCORI) to oversee the 
conduct of comparative effectiveness studies. These should inform coverage 
decisions, though Medicare is expressly forbidden from using economic 
evaluations in those coverage decisions. It is too early to assess PCORI’s 
impact on coverage and access to medical services.
RESOURCE ALLOCATION AND RATIONING IN EUROPE
In most European countries, the dominant source of health financing is 
public, based on taxation and social insurance contributions. Although in 
several poorer former Soviet countries, in particular in the Caucasus and 
Central Asia, private out-of-pocket expenditure has become the main 
source of health financing.19,20 Curative or rehabilitative services usually 
comprise the largest share of total health expenditure. Expenditure on 
prevention and public health services as a percentage of total health 
expenditure varies substantially across countries, ranging in 2009 in the 
European Economic Area (EEA) from 1.2 percent in Lithuania to 8.3 
percent in Romania.21
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Most health care systems in Europe (as well as Australia, Canada and 
Japan), whether they are predominantly tax- or insurance-financed, provide 
universal or near-universal population coverage to all people resident in the 
respective country. Health benefits are comprehensive and usually include 
preventive and public health services, primary care, ambulatory and 
inpatient care, prescription pharmaceuticals, mental health care, dental 
care, rehabilitation, home care and nursing home care.19 
The countries of Central and Eastern Europe formerly belonging to the 
Soviet bloc faced a different situation: they had inherited the Soviet-era 
commitment to universal coverage for a comprehensive range of services 
free at the point of use. However, this commitment used to be poorly 
financed in the Soviet period and was increasingly difficult to meet, as 
many countries faced severe transitional recessions in the 1990s, with a 
corresponding drop in government expenditure on health and a rise in 
informal out-of-pocket payments. Almost all former communist countries 
responded by defining benefit packages with a reduced scope of services 
and introducing official user fees for services outside the benefit packages, 
although in several countries, ranging from Hungary to Tajikistan, this 
met with considerable—and often—successful resistance.20,22,23 Despite 
differences in coverage, the role of both formal and informal out-of-pocket 
payments increased substantially, in particular in the poorer ex-Soviet 
countries, undermining the equity, efficiency and transparency of health 
care systems.20
Thus, while some countries in Europe had to reduce publicly financed 
coverage, others, including Belgium, France, Ireland, and the Netherlands, 
moved in the opposite direction and expanded entitlement to publicly 
funded health care.19 Ireland introduced universal entitlement to both 
hospital (1991) and primary care (2006), the latter subject to capped cost-
sharing for higher income households.24 In 2000, France introduced 
universal coverage, changing the basis of entitlement to publicly funded 
care from employment to citizenship and entitling those with low incomes 
to free coverage.25 Belgium, in 2008, extended full statutory coverage to all 
self-employed people, creating a single health risk pool for the first time.26 
Finally, in 2006 the Netherlands abolished the traditional divide between a 
compulsory social health insurance scheme for all employees with an 
income below a certain threshold and private health insurance for the 
remaining 30 percent of the population, so that the whole population became 
covered by a single health insurance scheme, operated by competitive 
private insurance funds.27 These changes to coverage resulted in greater 
financial equity and protection, as well as more equitable access to care.19
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A number of European countries have undertaken attempts to 
depoliticize decisions on rationing by using tools such as HTAs and setting 
up dedicated HTA agencies. In Sweden, economic assessments are 
combined with humanitarian and solidarity principles, as well as public 
involvement.28 Another example that has received international attention is 
the National Institute for Health and Clinical Excellence (NICE), set up in 
the United Kingdom in 1999 to reduce variations in the availability and 
quality of National Health Service (NHS) treatments and care in different 
parts of the country (the so-called ‘postcode lottery’). When appraising 
new technologies and issuing guidance, NICE reviews clinical and 
economic evidence, relying particularly on quality-adjusted life years 
(QALYs), and usually setting an upper threshold of GBP £30,000 per 
QALY. Several high profile cases, however, demonstrated that the 
government, the pharmaceutical industry and the media continue to wield 
influence on NICE recommendations, raising the question of which social 
values to uphold and how to make decisions on them.11,28,29
DISCUSSION
Resource allocation and rationing raise many ethical questions that differ 
considerably between the US and Europe. In the US, the breadth of 
coverage is a major issue, with a large part of the population left uninsured 
or poorly insured. In contrast, in most of Europe, population coverage is 
nearly universal. The major reason behind this difference is that Europe—
following the devastation of the Second World War—embraced various 
models of the welfare state built on the underlying notion of solidarity, 
whereas the US never faced that level of devastation and remained much 
more heterogeneous in its political values. 
These underlying perceptions of the welfare state have a direct impact 
on other aspects of rationing. The US, where social welfare remains 
politically controversial, places few restrictions on publicly financed health 
care technology, such as in the Medicare and Medicaid programs, regardless 
of cost or clinical effectiveness.13 European countries, on the other hand, 
are more willing to engage in explicit debates about what the limits of 
publicly funded health care should be. However, they face difficulties in 
putting these debates on a rational basis and limiting media and lobby 
power, with implications for the values that underpin decisions. 
8 Public Health Reviews, Vol. 34, No 1
CONCLUSION
Given the very different contexts of health care systems in the US and 
Europe, it is not surprising that ethical issues around rationing differ 
substantially. In the US, they largely revolve around rationing care by 
eligibility for insurance coverage, whereas in Europe they are more 
concerned with the scope of publicly funded services to all. With PPACA, 
the US has taken a major step towards expanding population coverage, 
effectively, but slowly, following the example of European countries. Faced 
with a sustained economic crisis, there is a growing recognition on both 
sides of the Atlantic of fiscal constraints and the need to contain health care 
costs. However, PPACA does little to address rising health care expenditure,30 
as an explicit discussion of rationing remains politically anathema in the 
US.13 What seems to be urgently needed in both the US and Europe are 
public debates about the financial sustainability of health systems, the 
trade-offs between cost-containment and broader societal and health system 
goals (such as increased population coverage and investment in other social 
goods), the role of the welfare state, and where the limits of publicly 
financed health care should be. 
Acronyms List:
HTA = Health technology assessment
NICE = National Institute for Health and Clinical Excellence
PCORI = Patient-Centered Outcomes Research Institute
PPACA = Patient Protection and Affordable Care Act
QALY = Quality-adjusted life year
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